Nomura Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $209K | Buy |
+5,742
| New | +$209K | ﹤0.01% | 672 |
|
2025
Q1 | – | Hold |
0
| – | – | – | 1487 |
|
2024
Q4 | – | Hold |
0
| – | – | – | 1648 |
|
2023
Q2 | – | Sell |
-329,170
| Closed | -$13.2M | – | 1032 |
|
2023
Q1 | $13.2M | Buy |
329,170
+101,182
| +44% | +$4.06M | 0.04% | 113 |
|
2022
Q4 | $10.6M | Buy |
227,988
+157,915
| +225% | +$7.32M | 0.04% | 144 |
|
2022
Q3 | $2.9M | Sell |
70,073
-7,939
| -10% | -$329K | 0.01% | 401 |
|
2022
Q2 | $4.89M | Buy |
+78,012
| New | +$4.89M | 0.02% | 340 |
|
2020
Q1 | – | Sell |
-6,574
| Closed | -$282K | – | 802 |
|
2019
Q4 | $282K | Buy |
+6,574
| New | +$282K | ﹤0.01% | 627 |
|